Insulet (PODD) Shares Outstanding (Diluted Average) (2016 - 2026)
Insulet (PODD) reported Shares Outstanding (Diluted Average) of $70.2 million for Q1 2026, down 5.27% on a YoY basis from $74.1 million in Q1 2025, and down 2.34% quarter-over-quarter from $71.9 million in Q4 2025.
Insulet (PODD) Shares Outstanding (Diluted Average) (2016 - 2026) Analysis & Trends
Insulet has reported Shares Outstanding (Diluted Average) for 11 years, with the latest figure at $70.2 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 5.27% year-over-year to $70.2 million; the trailing twelve-month figure through Mar 2026 stood at $70.2 million (down 5.27% YoY), and the FY2025 full-year result was $71.9 million, down 2.71% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $70.2 million, down from $71.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $74.1 million in Q1 2025, with the low at $69.3 million in Q2 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $71.8 million across 5 years, with a median of $71.9 million in 2025.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) advanced 6.17% — and 2026, when it slipped 5.27%.
- Insulet's Shares Outstanding (Diluted Average) stood at $69.9 million in 2022, then rose by 5.33% to $73.6 million in 2023, then climbed by 0.35% to $73.9 million in 2024, then fell by 2.71% to $71.9 million in 2025, then retreated by 2.34% to $70.2 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $70.2 million (Q1 2026), $71.9 million (Q4 2025), and $72.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 70.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.20 Mn |
| Dec 31, 2025 | 71.89 Mn |
| Sep 30, 2025 | 72.29 Mn |
| Jun 30, 2025 | 70.64 Mn |
| Mar 31, 2025 | 74.11 Mn |
| Dec 31, 2024 | 73.89 Mn |
| Sep 30, 2024 | 73.83 Mn |
| Jun 30, 2024 | 73.80 Mn |
| Mar 31, 2024 | 73.74 Mn |
| Dec 31, 2023 | 73.63 Mn |
| Sep 30, 2023 | 73.62 Mn |
| Jun 30, 2023 | 70.12 Mn |
| Mar 31, 2023 | 70.10 Mn |
| Dec 31, 2022 | 69.91 Mn |
| Sep 30, 2022 | 69.34 Mn |
| Jun 30, 2022 | 69.31 Mn |
| Mar 31, 2022 | 69.86 Mn |
| Dec 31, 2021 | 68.58 Mn |
| Sep 30, 2021 | 67.24 Mn |
| Jun 30, 2021 | 66.41 Mn |